Myriad Genetics is urging early carrier screening for spinal muscular atrophy, saying earlier genetic insight can speed diagnosis and intervention. The push ali

Myriad Genetics is urging early carrier screening for spinal muscular atrophy, saying earlier genetic insight can speed diagnosis and intervention. The push aligns with the company’s broader expansion of risk-assessment tools across genetic testing and cancer screening.